PreOmics
PreOmics is a company that develops and produces innovative technologies for the pre-analytics of samples for mass spectrometry.
PreOmics has raised €3.3M across 1 funding round from 1 investor, most recently a Series A round in Dec 2018. Based in Martinsried, Germany; founded 2016; active in Software. Data as of 28 Oct 2026.
Total raised
€3.3M
€3,300,000
Funding rounds
1
Investors
1
distinct backers
Active since
2018-12
latest 2018-12
Funding by year
EUR raised per yearPreOmics — funding by year — interactive chart.
Data table
| PreOmics — funding by year | |
|---|---|
| 2018 | €3.3M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2018-12-27 | Series A | €3.3M | Think.Health | View deal → |